b-AP15 is an inhibitor of the ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCHL5) and ubiquitin-specific-processing protease 14 (USP14). In purified 19S proteasomes, b-AP15 can inhibit DUB activity with an IC50 of 2.1 μM.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | DUB ↓ ↑ | UCH ↓ ↑ | USP/UBP ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PR-619 |
+
Plpro, EC50: 14.2 μM |
+++
UCH-L5, EC50: 12.8 μM UCH-L3, EC50: 2.95 μM |
+++
USP5, EC50: 4.90 μM USP28, EC50: 6.24 μM |
99%+ | |||||||||||||||
Degrasyn | ✔ | Bcr-Abl | 98+% | ||||||||||||||||
VLX1570 |
+
DUB, IC50: ~10 μM |
99%+ | |||||||||||||||||
ML-323 |
++++
USP1-UAF1, IC50: 76 nM |
99%+ | |||||||||||||||||
LDN-57444 |
++++
UCH-L1, IC50: 0.4 μM UCH-L3, IC50: 25 μM |
99%+ | |||||||||||||||||
TCID |
++++
UCH-L3, IC50: 0.6 μM |
98% | |||||||||||||||||
b-AP15 |
+++
UCHL5, IC50: 2.1 μM |
98% | |||||||||||||||||
P 22077 |
++
USP7, IC50: 8.6 μM USP47, EC50: 8.74 μM |
99%+ | |||||||||||||||||
P005091 |
++
USP47, IC50: 4.3 μM USP7, EC50: 4.2 μM |
99+% | |||||||||||||||||
IU1 |
++
USP14, IC50: 4.7 μM |
98% | |||||||||||||||||
NSC632839 |
+
USP2, EC50: 45 μM USP7, EC50: 37 μM |
99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
产品名称 | 20S proteasome ↓ ↑ | Proteasome ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ixazomib |
++++
20S proteasome, IC50: 3.4 nM 20S proteasome, Ki: 0.93 nM |
99%+ | |||||||||||||||||
Delanzomib |
+++
Chymotrypsin-like proteasome, IC50: 3.8 nM |
98% | |||||||||||||||||
Celastrol |
+
20S proteasome, IC50: 2.5 μM |
98% | |||||||||||||||||
MLN9708 |
+++
20S proteasome, IC50: 3.4 nM 20S proteasome, Ki: 0.93 nM |
99% | |||||||||||||||||
Bortezomib |
++++
20S proteasome, Ki: 0.6 nM |
98% | |||||||||||||||||
Oprozomib |
++
20S proteasome LMP7, IC50: 82 nM 20S proteasome β5, IC50: 36 nM |
99%+ | |||||||||||||||||
Epoxomicin | ✔ | 99% | |||||||||||||||||
PI-1840 |
++
Chymotrypsin-like proteasome, IC50: 27 nM |
98% | |||||||||||||||||
VR23 |
+++
Trypsin-like proteasomes, IC50: 1 nM Chymotrypsin-like proteasomes, IC50: 3 μM |
98% | |||||||||||||||||
Carfilzomib |
++
Proteasome, IC50: 5 nM |
98% | |||||||||||||||||
(R)-MG-132 |
+
Proteasome, IC50: 100 nM |
98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | The ubiquitin-specific peptidases (USPs) are the main members of the deubiquitinase(DUB) family. b-AP15 is an inhibitor of 19S proteasome deubiquitinase (DUB) with IC50 value of 6.5 μM[3]. In vitro, b-AP15 induced time- and dose-dependent apoptosis of the human multiple myeloma cell lines RPM18226 and U266. b-AP15 triggered processing of pro-caspase-3 and cleavage of ploy (ADP-ribose) polymerase in the human multiple myeloma cell. b-AP15 also induced caspase-independent apoptosis in primary human natural killer cells[4]. In vivo, administration of b-AP15 at 4 mg/kg once daily for 14 days was well tolerated, inhibited tumor growth, and prolong survival in human multiple myeloma xenograft models[5]. Treatment with b-AP15 at dose of 5 mg/kg inhibited tumor growth in SCID mice with FaDu human tumor xenograft and C57BL/6J mice with Lewis lung carcinomas (LLCs). Treatment with b-AP15 at dose of 2.5 mg/kg also inhibited tumor growth in BALB/c mice with orthotopic breast carcinoma. In addition, b-AP15 can inhibited organ infiltration in an acute myeloid leukemia model[6]. |
作用机制 | b-AP15 blocks the DUB activity of the 19S regulatory particle (19S RP) without inhibiting the proteolytic activities of the 20S core particle (20S CP), and inhibits two proteasome-associated DUBs, USP14 and UCHL5, resulting in a rapid accumulation of high molecular weight ubiquitin conjugates and a functional proteasome shutdown[7]. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
CEM cells | Cytotoxicity assay | Cytotoxicity against human CEM cells, IC50=0.26 μM | 19819135 | ||
HL60 cells | Cytotoxicity assay | Cytotoxicity against human HL60 cells in presence of RPMI1640 containing 10% fetal bovine serum by trypan blue exclusion test, CC50=0.13 μM | 17499885 | ||
HSC4 cells | Cytotoxicity assay | Cytotoxicity against human HSC4 cells by MTT method, CC50=0.56 μM | 17499885 | ||
human HSC2 | Cytotoxicity assay | Cytotoxicity against human HSC2 by MTT method, CC50=0.094 μM | 17499885 | ||
Dose | Mice: 2.5 mg/kg, 5 mg/kg[3] (i.p.) |
Administration | i.p. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.92mL 2.38mL 1.19mL |
23.84mL 4.77mL 2.38mL |
CAS号 | 1009817-63-3 |
分子式 | C22H17N3O6 |
分子量 | 419.387 |
别名 | NSC 687852 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 18 mg/mL(42.92 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
4% DMSO+corn oil 1 mg/mL |